|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pneumococcal Infections | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Infection | |||||
| 3 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Gram-Positive Bacterial Infections | |||||
| Streptococcal Infections | |||||
| 4 | Interventions listed in this trial | ||||
| Pneumovax or Pneumo23 | |||||
| Prevnar | |||||
| 5 | Sponsors listed in this trial | ||||
| Canadian HIV Trials Network | |||||
| Wyeth | |||||